R.E.N.A.L. nephrometry score predicts treatment efficacy

December 27, 2012
R.E.N.A.L. nephrometry score predicts treatment efficacy
The R.E.N.A.L. (radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior and location relative to polar lines) nephrometry scoring system predicts the efficacy of treatment and major complications that occur after percutaneous renal ablation for treatment of tumors, according to research published in the January issue of The Journal of Urology.

(HealthDay)—The R.E.N.A.L. (radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior and location relative to polar lines) nephrometry scoring system predicts the efficacy of treatment and major complications that occur after percutaneous renal ablation for treatment of tumors, according to research published in the January issue of The Journal of Urology.

Grant D. Schmit, M.D., of the Mayo Clinic in Rochester, Minn., and colleagues applied the R.E.N.A.L. criteria to 751 renal tumors in 627 patients to examine the correlation with oncological outcomes and complications after percutaneous ablation. Fifty-seven percent of tumors were treated with cryoablation and 43 percent were treated with radio frequency ablation.

The researchers found that the mean score for renal tumors treated with was significantly higher than for those treated with radio frequency ablation (7.2 ± 1.9 versus 6.1 ± 1.8). Over an average follow-up period of 27.9 months, 28 local treatment failures occurred. R.E.N.A.L. nephrometry score was significantly associated with local , with a mean score of 7.6 ± 2.2 in cases of failure versus 6.7 ± 1.9 in cases without failure. R.E.N.A.L. score was also significantly associated with major complications, with a mean score of 8.1 ± 2.0 in cases with a major complication versus 6.8 ± 1.9 in cases without a major complication.

"The R.E.N.A.L. nephrometry predicts oncological outcomes and complications following percutaneous renal ablation," the authors write. "As such, this tool may be used to facilitate the standardization of comparisons of treatment efficacy and safety across various approaches to small renal tumors."

One author disclosed to the medical device and technology industries.

Explore further: Similar outcomes for robot-aided, conventional nephrectomy

More information: Abstract
Full Text

Related Stories

Similar outcomes for robot-aided, conventional nephrectomy

June 22, 2012
(HealthDay) -- Robot-assisted and conventional laparoscopic partial nephrectomies have similar outcomes and complication rates, according to a study published in the July issue of The Journal of Urology.

Researcher identifies nearly 100 studies supporting use of thermal ablation to treat lung cancer

August 31, 2011
The journal Radiology will publish in its September issue an article written by Damian E. Dupuy, M.D., director of tumor ablation at Rhode Island Hospital, supporting the use of ablation procedures for the treatment of lung ...

Renal denervation gives better outcomes than drugs in advanced heart failure

August 27, 2012
Renal denervation leads to better outcomes than standard drug treatment in patients with advanced heart failure, according to research presented at ESC Congress 2012. The results of the Olomouc I pilot study were presented ...

Recommended for you

Researchers developing new tool to distinguish between viral, bacterial infections

July 28, 2017
Antibiotics are lifesaving drugs, but overuse is leading to one of the world's most pressing health threats: antibiotic resistance. Researchers at the University of Rochester Medical Center are developing a tool to help physicians ...

Finish your antibiotics course? Maybe not, experts say

July 27, 2017
British disease experts on Thursday suggested doing away with the "incorrect" advice to always finish a course of antibiotics, saying the approach was fuelling the spread of drug resistance.

Co-infection with two common gut pathogens worsens malnutrition in mice

July 27, 2017
Two gut pathogens commonly found in malnourished children combine to worsen malnutrition and impair growth in laboratory mice, according to new research published in PLOS Pathogens.

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

July 26, 2017
A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for giant cell arteritis, the ...

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.